Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cipla
Deloitte
Healthtrust
UBS
Fuji
McKesson
US Army
AstraZeneca

Generated: June 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017563

« Back to Dashboard

NDA 017563 describes FLAVORED COLESTID, which is a drug marketed by Pharmacia Upjohn and is included in one NDA. It is available from two suppliers. Additional details are available on the FLAVORED COLESTID profile page.

The generic ingredient in FLAVORED COLESTID is colestipol hydrochloride. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.
Summary for 017563
Tradename:FLAVORED COLESTID
Applicant:Pharmacia Upjohn
Ingredient:colestipol hydrochloride
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 017563
Mechanism of ActionBile-acid Binding Activity
Medical Subject Heading (MeSH) Categories for 017563
Suppliers and Packaging for NDA: 017563
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COLESTID colestipol hydrochloride GRANULE;ORAL 017563 NDA Pharmacia and Upjohn Company LLC 0009-0260 N 0009-0260-01
COLESTID colestipol hydrochloride GRANULE;ORAL 017563 NDA Pharmacia and Upjohn Company LLC 0009-0260 N 0009-0260-02

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GRANULE;ORALStrength5GM/PACKET
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:GRANULE;ORALStrength5GM/SCOOPFUL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:GRANULE;ORALStrength5GM/SCOOPFUL
Approval Date:Sep 22, 1995TE:ABRLD:Yes

Expired US Patents for NDA 017563

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Covington
QuintilesIMS
Chinese Patent Office
Deloitte
UBS
Cipla
Queensland Health
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.